| The CSF profile linked to cortical damage predicts multiple sclerosis activity R Magliozzi, A Scalfari, AI Pisani, S Ziccardi, D Marastoni, FB Pizzini, ... Annals of neurology 88 (3), 562-573, 2020 | 53 | 2020 |
| Potential neuroprotective effect of Fingolimod in multiple sclerosis and its association with clinical variables M Pitteri, R Magliozzi, A Bajrami, V Camera, M Calabrese Expert Opinion on Pharmacotherapy 19 (4), 387-395, 2018 | 28 | 2018 |
| Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events M Calabrese, M Pitteri, G Farina, A Bajrami, M Castellaro, R Magliozzi, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (12), 1073-1078, 2017 | 19 | 2017 |
| The effect of fingolimod on focal and diffuse grey matter damage in active MS patients A Bajrami, M Pitteri, M Castellaro, F Pizzini, C Romualdi, S Montemezzi, ... Journal of Neurology 265, 2154-2161, 2018 | 12 | 2018 |
| Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS A Bajrami, R Magliozzi, AI Pisani, FB Pizzini, F Crescenzo, D Marastoni, ... Multiple Sclerosis Journal 28 (4), 550-560, 2022 | 8 | 2022 |
| Unraveling the MRI‐Based Microstructural Signatures Behind Primary Progressive and Relapsing–Remitting Multiple Sclerosis Phenotypes I Boscolo Galazzo, L Brusini, M Akinci, F Cruciani, M Pitteri, S Ziccardi, ... Journal of Magnetic Resonance Imaging 55 (1), 154-163, 2022 | 6 | 2022 |
| Diffusion MRI and silver standard masks to improve CNN-based thalamus segmentation GR Pinheiro, L Brusini, A Bajrami, FB Pizzini, M Calabrese, F Reis, ... Medical Imaging 2021: Image Processing 11596, 692-698, 2021 | 3 | 2021 |
| Microstructural modulations in the hippocampus allow to characterizing relapsing-remitting versus primary progressive multiple sclerosis L Brusini, I Boscolo Galazzo, M Akinci, F Cruciani, M Pitteri, S Ziccardi, ... Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries …, 2021 | 2 | 2021 |
| Feasibility of detecting atrophy relevant for disability and cognition in multiple sclerosis using 3D-FLAIR S Noteboom, DR van Nederpelt, A Bajrami, B Moraal, MWA Caan, ... Journal of neurology 270 (11), 5201-5210, 2023 | 1 | 2023 |
| The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis EA Krijnen, TAA Broeders, S Noteboom, M van Dam, A Bajrami, ... Journal of neurology, 1-12, 2024 | | 2024 |
| CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis D Marastoni, M Foschi, C Eccher, F Crescenzo, V Mazziotti, A Tamanti, ... Frontiers in Immunology 15, 1343892, 2024 | | 2024 |
| Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis A Bajrami, A Tamanti, A Peloso, S Ziccardi, M Guandalini, M Calderone, ... Journal of Neurology, 1-10, 2024 | | 2024 |
| Cortical atrophy explains the relation between cortical lesions and cognitive decline in people with multiple sclerosis E Krijnen, M van Dam, A Bajrami, P Bouman, S Noteboom, F Barkhof, ... MULTIPLE SCLEROSIS JOURNAL 29, 248-249, 2023 | | 2023 |
| Cortical atrophy in cognitive networks is worst in non-lesional cortex in people with multiple sclerosis E Krijnen, A Bajrami, M van Dam, P Bouman, S Noteboom, F Barkhof, ... MULTIPLE SCLEROSIS JOURNAL 29, 249-250, 2023 | | 2023 |
| Feasibility of detecting atrophy relevant for disability and cognition on 3D-FLAIR S Noteboom, MD Steenwijk, DR van Nederpelt, EMM Strijbis, A Bajrami, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 270-271, 2022 | | 2022 |
| Distribution of cortical lesions across functional networks is non-random and related to cognitive impairment A Bajrami, EA Krijnen, TA Broeders, PM Bouman, M van Dam, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 275-276, 2022 | | 2022 |
| Cortical lesions in functional networks are related to cortical atrophy, but only in normal-appearing grey matter EA Krijnen, A Bajrami, M Van Dam, PM Bouman, S Noteboom, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 536-536, 2022 | | 2022 |
| Ocrelizumab reduces focal lesions and global/regional volume changes if compared to other second-line treatment A Bajrami, A Tamanti, A Peloso, A Colombi, M Castellaro, D Marastoni, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 1017-1017, 2022 | | 2022 |
| Early cortical and deep gray matter atrophy predicts disability progression independent of relapse in multiple sclerosis: a 17 year longitudinal study D Marastoni, A Bajrami, AI Pisani, E Colato, G Schiavi, S Ziccardi, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 171-171, 2022 | | 2022 |
| Regional altered diffusion in lesional and normal-appearing cortex is linked to cognitive impairment in multiple sclerosis EA Krijnen, A Bajrami, TA Broeders, S Noteboom, PM Bouman, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 535-536, 2022 | | 2022 |
